Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000053 |
|---|---|
| Form Type | 4 |
| Filing Date | May 9, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
80,000
Total Value
$5,952,050.43
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 8, 2026 | Sale | 2,404 | $72.57 | $174,458.28 | 166,202 | Direct | โ | View Details | |
Director | Common Stock | โ | May 8, 2026 | Sale | 33,513 | $73.72 | $2,470,578.36 | 132,689 | Direct | โ | View Details | |
Director | Common Stock | โ | May 8, 2026 | Sale | 24,814 | $74.76 | $1,855,094.64 | 107,875 | Direct | โ | View Details | |
Director | Common Stock | โ | May 8, 2026 | Sale | 19,269 | $75.35 | $1,451,919.15 | 88,606 | Direct | โ | View Details |